The P2X7 receptor-interleukin-1 liaison

Frontiers in Pharmacology

Volumn 8, Issue MAR, 2017, Pages

  Giuliani, Anna Lisa ^a   Sarti, Alba C ^a   Falzoni, Simonetta ^a   Di Virgilio, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Caspase 1; Inflammation; Interleukin 1 ; NLRP3 inflammasome; P2X7 receptor

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1BETA; PURINERGIC P2X7 RECEPTOR;

CELL DAMAGE; CELL TRANSPORT; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXOCYTOSIS; EXOSOME; HUMAN; INFLAMMATION; LYSOSOME; MEMBRANE MICROPARTICLE; MICROVESICLE SHEDDING; MOLECULARLY TARGETED THERAPY; NONHUMAN; PASSIVE EFFLUX; PLASMA DAMAGE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PYROPTOSIS; REVIEW;

EID: 85016152268     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00123     Document Type: Review

References (124)

1. Ainscough, J. S., Frank Gerberick, G., Zahedi-Nejad, M., Lopez-Castejon, G., Brough, D., Kimber, I., et al. (2014). Dendritic cell IL-1alpha and IL-1beta are polyubiquitinated and degraded by the proteasome. J. Biol. Chem. 289, 35582-35592. doi: 10.1074/jbc.M114.595686
2. Alves, L. A., de Melo Reis, R. A., de Souza, C. A., de Freitas, M. S., Teixeira, P. C., Neto Moreira Ferreira, D., et al. (2014). The P2X7 receptor: shifting from a low-to a high-conductance channel-an enigmatic phenomenon? Biochim. Biophys. Acta 1838, 2578-2587. doi: 10.1016/j.bbamem.2014.05.015
3. Andrei, C., Dazzi, C., Lotti, L., Torrisi, M. R., Chimini, G., and Rubartelli, A. (1999). The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10, 1463-1475. doi: 10.1091/mbc.10.5.1463
4. Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R., and Rubartelli, A. (2004). Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc. Natl. Acad. Sci. U.S.A. 101, 9745-9750. doi: 10.1073/pnas.0308558101
5. Antonucci, F., Turola, E., Riganti, L., Caleo, M., Gabrielli, M., Perrotta, C., et al. (2012). Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J. 31, 1231-1240. doi: 10.1038/emboj.2011.489
6. Baroja-Mazo, A., Barbera-Cremades, M., and Pelegrin, P. (2013). The participation of plasma membrane hemichannels to purinergic signaling. Biochim. Biophys. Acta 1828, 79-93. doi: 10.1016/j.bbamem.2012.01.002
7. Bartlett, R., Stokes, L., and Sluyter, R. (2014). The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol. Rev. 66, 638-675. doi: 10.1124/pr.113.008003
8. Beeson, P. B. (1948). Temperature-elevating effect of a substance obtained from polymorphonuclear leucocytes. J. Clin. Invest. 27, 524.
9. Benko, S., Philpott, D. J., and Girardin, S. E. (2008). The microbial and danger signals that activate Nod-like receptors. Cytokine 43, 368-373. doi: 10.1016/j.cyto.2008.07.013
10. Bergsbaken, T., Fink, S. L., and Cookson, B. T. (2009). Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7, 99-109. doi: 10.1038/nrmicro2070
11. Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., et al. (2009). Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28, 1043-1054. doi: 10.1038/emboj.2009.45
12. Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Moller, T., Matteoli, M., et al. (2005). Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 174, 7268-7277. doi: 10.4049/jimmunol.174.11.7268
13. Blott, E. J., and Griffiths, G. M. (2002). Secretory lysosomes. Nat. Rev. Mol. Cell Biol. 3, 122-131. doi: 10.1038/nrm732
14. Bodel, P., and Atkins, E. (1967). Release of endogenous pyrogen by human monocytes. N. Engl. J. Med. 276, 1002-1008. doi: 10.1056/NEJM196705042761803
15. Borthwick, L. A. (2016). The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin. Immunopathol. 38, 517-534. doi: 10.1007/s00281-016-0559-z
16. Bours, M. J., Swennen, E. L., Di Virgilio, F., Cronstein, B. N., and Dagnelie, P. C. (2006). Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112, 358-404. doi: 10.1016/j.pharmthera.2005.04.013
17. Brough, D., Le Feuvre, R. A., Wheeler, R. D., Solovyova, N., Hilfiker, S., Rothwell, N. J., et al. (2003). Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages. J. Immunol. 170, 3029-3036. doi: 10.4049/jimmunol.170.6.3029
18. Broz, P., and Dixit, V. M. (2016). Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407-420. doi: 10.1038/nri.2016.58
19. Cantiello, H. F. (2001). Electrodiffusional ATP movement through CFTR and other ABC transporters. Pflugers. Arch. 443(Suppl. 1), S22-S27. doi: 10.1007/s004240100639
20. Carta, S., Tassi, S., Semino, C., Fossati, G., Mascagni, P., Dinarello, C. A., et al. (2006). Histone deacetylase inhibitors prevent exocytosis of interleukin-1beta-containing secretory lysosomes: role of microtubules. Blood 108, 1618-1626. doi: 10.1182/blood-2006-03-014126
21. Cekic, C., and Linden, J. (2016). Purinergic regulation of the immune system. Nat. Rev. Immunol. 16, 177-192. doi: 10.1038/nri.2016.4
22. Dahl, G. (2015). ATP release through pannexon channels. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370:20140191. doi: 10.1098/rstb.2014.0191
23. De Marchi, E., Orioli, E., Dal Ben, D., and Adinolfi, E. (2016). P2X7 receptor as a therapeutic target. Adv. Protein Chem. Struct. Biol. 104, 39-79. doi: 10.1016/bs.apcsb.2015.11.004
24. Di Virgilio, F. (1995). The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16, 524-528. doi: 10.1016/0167-5699(95)80045-X
25. Di Virgilio, F. (2000). Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP. J. Auton. Nerv. Syst. 81, 59-63. doi: 10.1016/S0165-1838(00)00114-4
26. Di Virgilio, F. (2013). The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol. Rev. 65, 872-905. doi: 10.1124/pr.112.006171
27. Di Virgilio, F. (2015). P2X receptors and inflammation. Curr. Med. Chem. 22, 866-877. doi: 10.2174/0929867322666141210155311
28. Di Virgilio, F., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J. M., Venketaraman, V., et al. (1998). Cytolytic P2X purinoceptors. Cell Death Differ. 5, 191-199. doi: 10.1038/sj.cdd.4400341
29. Di Virgilio, F., Ferrari, D., Falzoni, S., Chiozzi, P., Munerati, M., Steinberg, T. H., et al. (1996). P2 purinoceptors in the immune system. Ciba Found. Symp. 198, 290-302; discussion302-295.
30. Dinarello, C. A. (1996). Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
31. Dinarello, C. A. (2005). Blocking IL-1 in systemic inflammation. J. Exp. Med. 201, 1355-1359. doi: 10.1084/jem.20050640
32. Dinarello, C. A. (2011). Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720-3732. doi: 10.1182/blood-2010-07-273417
33. Dinarello, C. A., and Bernheim, H. A. (1981). Ability of human leukocytic pyrogen to stimulate brain prostaglandin synthesis in vitro. J. Neurochem. 37, 702-708. doi: 10.1111/j.1471-4159.1982.tb12544.x
34. Dubyak, G. R. (2007). Go it alone no more-P2X7 joins the society of heteromeric ATP-gated receptor channels. Mol. Pharmacol. 72, 1402-1405. doi: 10.1124/mol.107.042077
35. Dubyak, G. R. (2012). P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol. 14, 1697-1706. doi: 10.1111/cmi.12001
36. Eder, C. (2009). Mechanisms of interleukin-1beta release. Immunobiology 214, 543-553. doi: 10.1016/j.imbio.2008.11.007
37. Eltzschig, H. K., Sitkovsky, M. V., and Robson, S. C. (2012). Purinergic signaling during inflammation. N. Engl. J. Med. 367, 2322-2333. doi: 10.1056/NEJMra1205750
38. Evans, W. H., De Vuyst, E., and Leybaert, L. (2006). The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem. J. 397, 1-14. doi: 10.1042/BJ20060175
39. Facci, L., Barbierato, M., Marinelli, C., Argentini, C., Skaper, S. D., and Giusti, P. (2014). Toll-like receptors 2,-3 and-4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1beta release. Sci. Rep. 4:6824. doi: 10.1038/srep06824
40. Fantuzzi, G., Ku, G., Harding, M. W., Livingston, D. J., Sipe, J. D., Kuida, K., et al. (1997). Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J. Immunol. 158, 1818-1824.
41. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Baricordi, O. R., et al. (1997). Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451-1458.
42. Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., et al. (2006). The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176, 3877-3883. doi: 10.4049/jimmunol.176.7.3877
43. Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi-Castagnoli, P., and Di Virgilio, F. (1996). Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156, 1531-1539.
44. Franceschini, A., Capece, M., Chiozzi, P., Falzoni, S., Sanz, J. M., Sarti, A. C., et al. (2015). The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J. 29, 2450-2461. doi: 10.1096/fj.14-268714
45. Gabay, C., Lamacchia, C., and Palmer, G. (2010). IL-1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 6, 232-241. doi: 10.1038/nrrheum.2010.4
46. Gallucci, S., Lolkema, M., and Matzinger, P. (1999). Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255. doi: 10.1038/15200
47. Garlanda, C., Dinarello, C. A., and Mantovani, A. (2013). The interleukin-1 family: back to the future. Immunity 39, 1003-1018. doi: 10.1016/j.immuni.2013.11.010
48. Gery, I., and Waksman, B. H. (1972). Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J. Exp. Med. 136, 143-155. doi: 10.1084/jem.136.1.143
49. Ginaldi, L., Di Benedetto, M. C., and De Martinis, M. (2005). Osteoporosis, inflammation and ageing. Immun. Ageing 2:14. doi: 10.1186/1742-4933-2-14
50. Grimes, L., and Young, M. T. (2015). Purinergic P2X receptors: structural and functional features depicted by X-ray and molecular modelling studies. Curr. Med. Chem. 22, 783-798. doi: 10.2174/0929867321999141212131457
51. Gudipaty, L., Munetz, J., Verhoef, P. A., and Dubyak, G. R. (2003). Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am. J. Physiol. Cell Physiol. 285, C286-C299. doi: 10.1152/ajpcell.00070.2003
52. Guo, H., Callaway, J. B., and Ting, J. P. (2015). Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21, 677-687. doi: 10.1038/nm.3893
53. Hammad, H., and Lambrecht, B. N. (2015). Barrier epithelial cells and the control of type 2 immunity. Immunity 43, 29-40. doi: 10.1016/j.immuni.2015.07.007
54. Hattori, M., and Gouaux, E. (2012). Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485, 207-212. doi: 10.1038/nature11010
55. Hauser, C., Dayer, J. M., Jaunin, F., de Rochemonteix, B., and Saurat, J. H. (1986). Intracellular epidermal interleukin 1-like factors in the human epidermoid carcinoma cell line A431. Cell Immunol. 100, 89-96. doi: 10.1016/0008-8749(86)90009-2
56. He, W. T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., et al. (2015). Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res. 25, 1285-1298. doi: 10.1038/cr.2015.139
57. He, Y., Hara, H., and Nunez, G. (2016a). Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem. Sci. 41, 1012-1021. doi: 10.1016/j.tibs.2016.09.002
58. He, Y., Zeng, M. Y., Yang, D., Motro, B., and Nunez, G. (2016b). NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354-357. doi: 10.1038/nature16959
59. Heid, M. E., Keyel, P. A., Kamga, C., Shiva, S., Watkins, S. C., and Salter, R. D. (2013). Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J. Immunol. 191, 5230-5238. doi: 10.4049/jimmunol.1301490
60. Hogquist, K. A., Nett, M. A., Unanue, E. R., and Chaplin, D. D. (1991). Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. U.S.A. 88, 8485-8489. doi: 10.1073/pnas.88.19.8485
61. Idzko, M., Ferrari, D., and Eltzschig, H. K. (2014). Nucleotide signalling during inflammation. Nature 509, 310-317. doi: 10.1038/nature13085
62. Jacobson, K. A., and Muller, C. E. (2016). Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology 104, 31-49. doi: 10.1016/j.neuropharm.2015.12.001
63. Janeway, C. A. Jr. (2001). How the immune system works to protect the host from infection: a personal view. Proc. Natl. Acad. Sci. U.S.A. 98, 7461-7468. doi: 10.1073/pnas.131202998
64. Jiang, L. H., Baldwin, J. M., Roger, S., and Baldwin, S. A. (2013). Insights into the molecular mechanisms underlying Mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms. Front. Pharmacol. 4:55. doi: 10.3389/fphar.2013.00055
65. Joosten, L. A., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M., Sparrer, H., et al. (2009). Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum. 60, 3651-3662. doi: 10.1002/art.25006
66. Junger, W. G. (2011). Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 11, 201-212. doi: 10.1038/nri2938
67. Kampschmidt, R. F., Pulliam, L. A., and Upchurch, H. F. (1973). Sources of leukocytic endogenous mediator in the rat. Proc. Soc. Exp. Biol. Med. 144, 882-886. doi: 10.3181/00379727-144-37703
68. Karasawa, A., and Kawate, T. (2016). Structural basis for subtype-specific inhibition of the P2X7 receptor. Elife 5:e22153. doi: 10.7554/eLife.22153
69. Karmakar, M., Katsnelson, M. A., Dubyak, G. R., and Pearlman, E. (2016). Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1beta secretion in response to ATP. Nat. Commun. 7:10555. doi: 10.1038/ncomms10555
70. Katsnelson, M. A., Rucker, L. G., Russo, H. M., and Dubyak, G. R. (2015). K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling. J. Immunol. 194, 3937-3952. doi: 10.4049/jimmunol.1402658
71. Kawate, T., Michel, J. C., Birdsong, W. T., and Gouaux, E. (2009). Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460, 592-598. doi: 10.1038/nature08198
72. Kayagaki, N., Stowe, I. B., Lee, B. L., O'Rourke, K., Anderson, K., Warming, S., et al. (2015). Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666-671. doi: 10.1038/nature15541
73. Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., et al. (2014). Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 3:e955691. doi: 10.4161/21624011.2014.955691
74. Kim, Y. K., Shin, J. S., and Nahm, M. H. (2016). NOD-like receptors in infection, immunity, and diseases. Yonsei Med. J. 57, 5-14. doi: 10.3349/ymj.2016.57.1.5
75. Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y. C., et al. (1984). Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312, 458-462. doi: 10.1038/312458a0
76. MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., and Surprenant, A. (2001). Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15, 825-835. doi: 10.1016/S1074-7613(01)00229-1
77. Mansoor, S. E., Lu, W., Oosterheert, W., Shekhar, M., Tajkhorshid, E., and Gouaux, E. (2016). X-ray structures define human P2X3 receptor gating cycle and antagonist action. Nature 538, 66-71. doi: 10.1038/nature19367
78. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., et al. (2004). Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218. doi: 10.1038/nature02664
79. Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., et al. (2006). Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232. doi: 10.1038/nature04515
80. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell. 10, 417-426. doi: 10.1016/S1097-2765(02)00599-3
81. Martin-Sanchez, F., Diamond, C., Zeitler, M., Gomez, A. I., Baroja-Mazo, A., Bagnall, J., et al. (2016). Inflammasome-dependent IL-1beta release depends upon membrane permeabilisation. Cell Death Differ. 23, 1219-1231. doi: 10.1038/cdd.2015.176
82. Menkin, V. (1943). Studies on the isolation of the factor responsible for tissue injury in inflammation. Science 97, 165-167. doi: 10.1126/science.97.2511.165
83. Minkiewicz, J., de Rivero Vaccari, J. P., and Keane, R. W. (2013). Human astrocytes express a novel NLRP2 inflammasome. Glia 61, 1113-1121. doi: 10.1002/glia.22499
84. Munoz-Planillo, R., Kuffa, P., Martinez-Colon, G., Smith, B. L., Rajendiran, T. M., and Nunez, G. (2013). K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142-1153. doi: 10.1016/j.immuni.2013.05.016
85. Murgia, M., Hanau, S., Pizzo, P., Rippa, M., and Di Virgilio, F. (1993). Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268, 8199-8203.
86. Nakahira, K., Haspel, J. A., Rathinam, V. A., Lee, S. J., Dolinay, T., Lam, H. C., et al. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222-230. doi: 10.1038/ni.1980
87. Nie, Y., Yang, D., and Oppenheim, J. J. (2016). Alarmins and antitumor immunity. Clin. Ther. 38, 1042-1053. doi: 10.1016/j.clinthera.2016.03.021
88. North, R. A. (2016). P2X receptors. Philos. Trans. R. Soc. Lond. B Biol. Sci. 371, 20150427. doi: 10.1098/rstb.2015.0427
89. Ogura, Y., Sutterwala, F. S., and Flavell, R. A. (2006). The inflammasome: first line of the immune response to cell stress. Cell 126, 659-662. doi: 10.1016/j.cell.2006.08.002
90. Pelegrin, P., Barroso-Gutierrez, C., and Surprenant, A. (2008). P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J. Immunol. 180, 7147-7157. doi: 10.4049/jimmunol.180.11.7147
91. Pelegrin, P., and Surprenant, A. (2007). Pannexin-1 couples to maitotoxin-and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J. Biol. Chem. 282, 2386-2394. doi: 10.1074/jbc.M610351200
92. Pellegatti, P., Falzoni, S., Pinton, P., Rizzuto, R., and Di Virgilio, F. (2005). A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 16, 3659-3665. doi: 10.1091/mbc.E05-03-0222
93. Perregaux, D., Barberia, J., Lanzetti, A. J., Geoghegan, K. F., Carty, T. J., and Gabel, C. A. (1992). IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin. J. Immunol. 149, 1294-1303.
94. Perregaux, D., and Gabel, C. A. (1994). Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269, 15195-15203.
95. Pizzirani, C., Ferrari, D., Chiozzi, P., Adinolfi, E., Sandona, D., Savaglio, E., et al. (2007). Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109, 3856-3864. doi: 10.1182/blood-2005-06-031377
96. Prochnicki, T., Mangan, M. S., and Latz, E. (2016). Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res 5:F1000. doi: 10.12688/f1000research.8614.1
97. Qu, Y., Franchi, L., Nunez, G., and Dubyak, G. R. (2007). Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179, 1913-1925. doi: 10.4049/jimmunol.179.3.1913
98. Qu, Y., Ramachandra, L., Mohr, S., Franchi, L., Harding, C. V., Nunez, G., et al. (2009). P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J. Immunol. 182, 5052-5062. doi: 10.4049/jimmunol.0802968
99. Rada, B., Park, J. J., Sil, P., Geiszt, M., and Leto, T. L. (2014). NLRP3 inflammasome activation and interleukin-1beta release in macrophages require calcium but are independent of calcium-activated NADPH oxidases. Inflamm. Res. 63, 821-830. doi: 10.1007/s00011-014-0756-y
100. Ramachandra, L., Qu, Y., Wang, Y., Lewis, C. J., Cobb, B. A., Takatsu, K., et al. (2010). Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infect. Immun. 78, 5116-5125. doi: 10.1128/IAI.01089-09
101. Rathinam, V. A., and Fitzgerald, K. A. (2016). Inflammasome complexes: emerging mechanisms and effector functions. Cell 165, 792-800. doi: 10.1016/j.cell.2016.03.046
102. Rubartelli, A., Cozzolino, F., Talio, M., and Sitia, R. (1990). A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9, 1503-1510.
103. Salaro, E., Rambaldi, A., Falzoni, S., Amoroso, F. S., Franceschini, A., Sarti, A. C., et al. (2016). Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. Sci. Rep. 6:26280. doi: 10.1038/srep26280
104. Sanman, L. E., van der Linden, W. A., Verdoes, M., and Bogyo, M. (2016). Bifunctional probes of cathepsin protease activity and pH reveal alterations in endolysosomal pH during bacterial infection. Cell Chem. Biol. 23, 793-804. doi: 10.1016/j.chembiol.2016.05.019
105. Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., et al. (2009). Activation of microglia by amyloid (beta) requires P2X7 receptor expression. J. Immunol. 182, 4378-4385. doi: 10.4049/jimmunol.0803612
106. Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821-832. doi: 10.1016/j.cell.2010.01.040
107. Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., et al. (2015). Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660-665. doi: 10.1038/nature15514
108. Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., et al. (2014). Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514, 187-192. doi: 10.1038/nature13683
109. Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., et al. (2012). Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401-414. doi: 10.1016/j.immuni.2012.01.009
110. Sneddon, P., and Westfall, D. P. (1984). Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J. Physiol. 347, 561-580. doi: 10.1113/jphysiol.1984.sp015083
111. Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., et al. (2001). Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276, 125-132. doi: 10.1074/jbc.M006781200
112. Suadicani, S. O., Brosnan, C. F., and Scemes, E. (2006). P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling. J. Neurosci. 26, 1378-1385. doi: 10.1523/JNEUROSCI.3902-05.2006
113. Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., and Buell, G. (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735-738. doi: 10.1126/science.272.5262.735
114. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., et al. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774. doi: 10.1038/356768a0
115. Turola, E., Furlan, R., Bianco, F., Matteoli, M., and Verderio, C. (2012). Microglial microvesicle secretion and intercellular signaling. Front. Physiol. 3:149. doi: 10.3389/fphys.2012.00149
116. Venereau, E., Ceriotti, C., and Bianchi, M. E. (2015). DAMPs from cell death to new life. Front. Immunol. 6:422. doi: 10.3389/fimmu.2015.00422
117. Verderio, C., Muzio, L., Turola, E., Bergami, A., Novellino, L., Ruffini, F., et al. (2012). Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann. Neurol. 72, 610-624. doi: 10.1002/ana.23627
118. Vigano, E., Diamond, C. E., Spreafico, R., Balachander, A., Sobota, R. M., and Mortellaro, A. (2015). Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat. Commun. 6:8761. doi: 10.1038/ncomms9761
119. Vince, J. E., and Silke, J. (2016). The intersection of cell death and inflammasome activation. Cell Mol. Life Sci. 73, 2349-2367. doi: 10.1007/s00018-016-2205-2
120. Walev, I., Reske, K., Palmer, M., Valeva, A., and Bhakdi, S. (1995). Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J. 14, 1607-1614.
121. Wang, Y., Martins, I., Ma, Y., Kepp, O., Galluzzi, L., and Kroemer, G. (2013). Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy 9, 1624-1625. doi: 10.4161/auto.25873
122. Wewers, M. D. (2004). IL-1beta: an endosomal exit. Proc. Natl. Acad. Sci. U.S.A. 101, 10241-10242. doi: 10.1073/pnas.0403971101
123. Yang, D., He, Y., Munoz-Planillo, R., Liu, Q., and Nunez, G. (2015). Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 43, 923-932. doi: 10.1016/j.immuni.2015.10.009
124. Zhou, R., Yazdi, A. S., Menu, P., and Tschopp, J. (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225. doi: 10.1038/nature09663